This whitepaper is for information purposes only and may be subject to change.
Corona Swiss AG (“Corona”) cannot guarantee the accuracy of the statements made or conclusions reached in this whitepaper. Corona does not make and expressly disclaims all representations and warranties (whether express or implied by statute or otherwise) whatsoever, including but not limited to: any representations or warranties relating to merchantability, fitness for a particular purpose, description, suitability or non-infringement; that the contents of this document are accurate and free from any errors; and that such contents do not infringe any third party rights.
Corona shall have no liability or damages of any kind arising out of the use, reference to or reliance on the contents of this whitepaper. This whitepaper may contain references to third-party data and industry publications. As far as Corona is aware, the information reproduced in this whitepaper is accurate and that its estimates and assumptions are reasonable. However, there are no assurances as to the accuracy or completeness of this information.
Although information and data reproduced in this whitepaper are believed to have been obtained from reliable sources, we have not independently verified any of the information or data from third party sources referred to in this whitepaper or ascertained the underlying assumptions relied upon by such sources. As of the date of publication of this whitepaper, Corona is not aware of any potential uses outside of the BIOHAL Ecosystem and are currently not permitted to be sold or otherwise traded on third-party exchanges.
This whitepaper does not constitute advice nor a recommendation by Corona, its officers, directors, manager, employees, agents, advisors, or consultants, or any other person to any recipient of this paper on the merits of participation in the BIOHAL Token Sale. Participation in the BIOHAL Token Sale carries substantial risk that could lead to a loss of all or a substantial portion of funds used to purchase the Token.
No promises of future performance or value are or will be made with respect to Tokens, including no promise of inherent value, no promise of continuing payments, and no guarantee that PON Tokens will hold any particular value. Unless prospective participants fully understand and accept the nature of BIOHAL’s proposed business and the potential risks inherent in PON Tokens, they should not participate in the BIOHAL Token Sale.
PON Tokens are not being structured or sold as securities. PON Tokens are not a participation in BIOHAL and PON Tokens hold no rights in BIOHAL. PON Tokens are sold with an intended future functionality on and access to the platform to be developed by Corona and all proceeds received during the Token Sale may be spent freely, by BIOHAL.
This whitepaper does not constitute a prospectus or offering document and is not an offer to sell, nor the solicitation of an offer to buy any investment or financial instrument in any jurisdiction. PON Tokens should not be acquired for speculative or investment purposes with the expectation of making an investment return. No regulatory authority has examined or approved any of the information set out in this whitepaper. No such action has been or will be taken under the laws, regulatory requirements or rules of any jurisdiction. The publication, distribution, or dissemination of this whitepaper does not imply that applicable laws, regulatory requirements or rules have been complied with. PON Tokens could be impacted by regulatory action and changes, including potential restrictions on the ownership, use, or possession of such tokens. Regulators or other competent authorities may demand that PON Tokens revises the mechanics and functionality of PON Tokens to comply with regulatory requirements or other governmental or business obligations. Nevertheless, BIOHAL believe they have taken commercially reasonable steps to ensure that its planned mechanics are proper and in compliance with currently considered regulations.
Corona is in the process of undertaking further legal and regulatory analysis of the functionality and mechanics of PON Tokens. Following the conclusion of this analysis, we may be required to amend the functionality of PON Tokens in order to ensure compliance with any legal or regulatory obligations that apply to us. We shall update this whitepaper and publish a notice on our website in the event that any changes are made to the PON Token.
CAUTION REGARDING FORWARD-LOOKING STATEMENTS
This whitepaper contains forward-looking statements or information (collectively “forward-looking statements”) that relate to BIOHAL’s current expectations and views of future events. In some cases, these forward-looking statements can be identified by words or phrases such as “may”, “will”, “expect”, “anticipate”, “aim”, “estimate”, “intend”, “plan”, “seek”, “believe”, “potential”, “continue”, “is/are likely to” or the negative of these terms, or other similar expressions intended to identify forward-looking statements.
Corona has based these forward-looking statements on its current expectations and projections about future events that it believes may affect its financial condition, results of operations, business strategy, financial needs, or the results of the token sale or the value or price stability of PON Tokens.
In addition to statements relating to the matters set out here, this whitepaper contains forward-looking statements related to BIOHAL’s proposed operating model. The model speaks to its objectives only, and is not a forecast, projection or prediction of future results of operations. Forward-looking statements are based on certain assumptions and analysis made by Corona in light of its experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate, and are subject to risks and uncertainties. Although the forward-looking statements contained in this whitepaper are based upon what Corona believes are reasonable assumptions, these risks, uncertainties, assumptions, and other factors could cause BIOHAL’s actual results, performance, achievements, and experience to differ materially from its expectations which are expressed, implied, or perceived in forward-looking statements. Given such risks, prospective participants in this token sale should not place undue reliance on these forward-looking statements.
Corona Swiss AG (”We”) are committed to protecting and respecting your privacy.
INFORMATION WE COLLECT FROM YOU
We will collect and process the following data about you:
Information we collect about you.
With regard to each of your visits to our site we will automatically collect the following information:
technical information, including the Internet protocol (IP) address used to connect your computer to the Internet, browser type and version, time zone setting, browser plug-in types and versions, operating system and platform;
information about your visit, including the full Uniform Resource Locators (URL), clickstream to, through and from our site (including date and time), page response times, download errors, length of visits to certain pages, page interaction information (such as scrolling, clicks, and mouse-overs), methods used to browse away from the page and any phone number used to call our customer service number.
Information we receive from other sources.
This is information we receive about you if you use any of the other websites we operate or the other services we provide. In this case, we will have informed you when we collected that data if we intend to share those data internally and combine it with data collected on this site. We will also have told you for what purpose we will share and combine your data. We are working closely with third parties (including, for example, business partners, sub-contractors in technical, payment and delivery services, advertising networks, analytics providers, search information providers, credit reference agencies). We will notify you when we receive information about you from them and the purposes for which we intend to use that information.
USES MADE OF THE INFORMATION
We use information held about you in the following ways:
Information you give to us.
We will use this information:
to carry out our obligations arising from any contracts entered into between you and us and to provide you with the information, products and services that you request from us;
to provide you with information about other goods and services we offer that are similar to those that you have already purchased or enquired about;
to provide you, or permit selected third parties to provide you, with information about goods or services we feel may interest you. If you are an existing customer, we will only contact you by electronic means (e-mail or SMS) with information about goods and services similar to those which were the subject of a previous sale or negotiations of a sale to you. If you are a new customer, and where we permit selected third parties to use your data, we (or they) will contact you by electronic means only if you have consented to this. If you do not want us to use your data in this way, or to pass your details on to third parties for marketing purposes, please tick the relevant box situated on the form on which we collect your data (the [order form OR registration form]);
to notify you about changes to our service;
to ensure that content from our site is presented in the most effective manner for you and for your computer.
Information we collect about you.
We will use this information:
to administer our site and for internal operations, including troubleshooting, data analysis, testing, research, statistical and survey purposes;
to improve our site to ensure that content is presented in the most effective manner for you and for your computer;
to allow you to participate in interactive features of our service, when you choose to do so;
as part of our efforts to keep our site safe and secure;
to measure or understand the effectiveness of advertising we serve to you and others, and to deliver relevant advertising to you;
to make suggestions and recommendations to you and other users of our site about goods or services that may interest you or them.
Information we receive from other sources.
We will combine this information with information you give to us and information we collect about you. We will use this information and the combined information for the purposes set out above (depending on the types of information we receive).
DISCLOSURE OF YOUR INFORMATION
You agree that we have the right to share your personal information with:
Any member of our group, which means our subsidiaries, our ultimate holding company, and its subsidiaries.
Selected third parties including:
business partners, suppliers, and sub-contractors for the performance of any contract we enter into with them or you;
advertisers and advertising networks that require the data to select and serve relevant adverts to you and others. We do not disclose information about identifiable individuals to our advertisers, but we will provide them with aggregate information about our users (for example, we may inform them that 500 men aged under 30 have clicked on their advertisement on any given day). We may also use such aggregate information to help advertisers reach the kind of audience they want to target (for example, women in SW1). We may make use of the personal data we have collected from you to enable us to comply with our advertisers’ wishes by displaying their advertisement to that target audience;
analytics and search engine providers that assist us in the improvement and optimization of our site;
credit reference agencies to assess your credit score where this is a condition of us entering into a contract with you.
We will disclose your personal information to third parties:
In the event that we sell or buy any business or assets, in which case we will disclose your personal data to the prospective seller or buyer of such business or assets.
If CORONA SWISS AG or substantially all of its assets are acquired by a third party, in which personal case data held by it about its customers will be one of the transferred assets.
WHERE WE STORE YOUR PERSONAL DATA
All information you provide to us is stored on our secure servers. Any payment transactions will be encrypted using SSL technology. Where we have given you (or where you have chosen) a password which enables you to access certain parts of our site, you are responsible for keeping this password confidential. We ask you not to share a password with anyone.
Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our site; any transmission is at your own risk. Once we have received your information, we will use strict procedures and security features to try to prevent unauthorized access.
You have the right to ask us not to process your personal data for marketing purposes. We will usually inform you (before collecting your data) if we intend to use your data for such purposes or if we intend to disclose your information to any third party for such purposes. You can exercise your right to prevent such processing by checking certain boxes on the forms we use to collect your data. You can also exercise the right at any time by contacting at firstname.lastname@example.org.
Our site may, from time to time, contain links to and from the websites of our partner networks, advertisers and affiliates. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.
ACCESS TO INFORMATION
The Act gives you the right to access information held about you. Your right of access can be exercised in accordance with the Act. Any access request will be subject to a fee of £100 to meet our costs in providing you with details of the information we hold about you.